Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT01615198 Completed - Clinical trials for Essential Hypertension

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

Start date: August 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to access the efficacy and safety of LCZ696 compared to olmesartan in elderly Asian patients for the treatment of hypertension.

NCT ID: NCT01599104 Completed - Clinical trials for Essential Hypertension

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

Start date: June 2012
Phase: Phase 3
Study type: Interventional

This study assessed the efficacy of LCZ696 in Japanese patients with essential hypertension

NCT ID: NCT01566188 Completed - Metabolic Syndrome Clinical Trials

Vascular Impact of Omega-3 in Metabolic Syndrome

CARDIOMEGA
Start date: January 2011
Phase: N/A
Study type: Interventional

The overall aims of the present project are to investigate the impact of a nutritional approach based on omega-3 from vegetal origin on vascular function in hypertension associated with metabolic syndrome.

NCT ID: NCT01556997 Completed - Clinical trials for Essential Hypertension

Perindopril Amlodipine for the Treatment of Hypertension

PATH
Start date: February 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of a fixed-dose combination drug compared to two other drugs (monotherapies) in controlling hypertension.

NCT ID: NCT01541943 Completed - Hyperlipidemia Clinical Trials

Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

Start date: March 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of HL-040XC in patients with essential hypertension and hyperlipidemia

NCT ID: NCT01523067 Completed - Clinical trials for Essential Hypertension

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Start date: January 2012
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the safety and tolerability of single ascending doses of Vasomera (PB1046) administered subcutaneously in adult subjects with Stage 1 or Stage 2 essential hypertension. The secondary objectives of the study are to characterize the pharmacokinetic profile of single ascending doses of Vasomera and the relationship between serum concentrations of Vasomera and change in systolic and diastolic blood pressure as measured by: - Mean change from baseline in 24-hour systolic and diastolic blood pressure measured by ambulatory blood pressure monitoring (ABPM) as compared to placebo. - Identification of the minimum and maximum decrease in systolic and diastolic blood pressure as measured by ABPM. - Mean change from baseline in cuff systolic and diastolic blood pressure as compared to placebo. - Effect of Vasomera on pulse pressure and heart rate. An additional secondary objective of this study will be to characterize the immunogenicity profile of Vasomera following a single subcutaneous dose.

NCT ID: NCT01456169 Completed - Clinical trials for Essential Hypertension

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Start date: October 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of the fixed dose combinations of azilsartan medoxomil plus chlorthalidone (40/12.5 and 40/25 mg), once daily, in participants with grades 2 or 3 essential hypertension who do not reach target blood pressure following treatment with 40 mg azilsartan medoxomil monotherapy after 4 weeks.

NCT ID: NCT01342614 Completed - Diabetes Mellitus Clinical Trials

The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension

Start date: May 2006
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effect of metformin on the correlation between hyperinsulinemia and hypertension.

NCT ID: NCT01307046 Completed - Hypertension Clinical Trials

MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

Start date: March 29, 2011
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy of MK-0954A in essential hypertension participants who are not adequately controlled with losartan.

NCT ID: NCT01307033 Completed - Hypertension Clinical Trials

A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

Start date: March 29, 2011
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the safety of MK-0954A (L100/H12.5 mg) in essential hypertension participants who are uncontrolled with MK-954H (L50/H12.5 mg).